Pub Date : 2025-12-18eCollection Date: 2026-01-01DOI: 10.1016/j.eclinm.2025.103702
Anteneh Asefa, Lenka Beňová, Bruno Marchal, Charlotte Hanlon, Tamba Mina Millimouno, Mariamawit Asfaw, Özge Tunçalp, Tom Smekens, Alexandre Delamou, Samson Gebremedhin
Background: The mistreatment of women during facility-based childbirth is widespread in sub-Saharan Africa and has a negative impact on women's mental health. We aimed to examine the association between childbirth-related mistreatment and postpartum depression in Ethiopia and Guinea.
Methods: Between May 2023 and February 2024, we conducted a prospective longitudinal survey of pregnant women recruited from 22 health facilities in Addis Ababa, Ethiopia, and 20 health facilities in Conakry, Guinea. Participants were surveyed during the third trimester in health facilities and were followed up in the community for a second survey, which was conducted between 6 and 16 weeks postpartum. Depression was assessed using the Edinburgh Postnatal Depression Scale (EPDS), and mistreatment was measured across seven categories. We used multilevel mixed effects Poisson regression to assess the association between the number of mistreatment categories experienced and women's postpartum depression scores.
Findings: Of the 859 women enrolled during pregnancy, 711 women completed the postpartum survey. 87.4% of women in Addis Ababa and 71.2% in Conakry had experienced at least one category of mistreatment. Symptoms suggestive of postpartum depression (EPDS ≥11) were reported by 20.9% of women in Addis Ababa and 31.0% in Conakry. After adjusting for antepartum depression, intimate partner violence, and other sociodemographic, obstetric, and health service-related characteristics, experience of each additional mistreatment category was associated with a 5% increase in women's postpartum depression scores (adjusted incidence rate ratio [AIRR] = 1.05, 95% CI: 1.01-1.09). Among women without symptoms suggestive of antepartum depression (EPDS <11), the effect was even greater, with an 11% increase in postpartum depression scores (AIRR = 1.11; 95% CI: 1.06-1.17).
Interpretation: The strong association between mistreatment and postpartum depression, particularly among women without antenatal depressive symptoms, highlights the potential causal role of mistreatment and underscores the urgent need for coordinated, evidence-informed, and context-appropriate strategies to promote respectful maternity care and safeguard women's mental health.
Funding: Research Foundation Flanders (FWO file number 1261923N) and the Institute of Tropical Medicine (ITM), Antwerp, Belgium, with support from the Flemish Government Department of Economy, Science and Innovation (EWI) and the Belgian Federal Directorate-General for Development Cooperation and Humanitarian Aid (DGD).
{"title":"Unraveling the link between the mistreatment of women during childbirth and postpartum depression: a prospective longitudinal study in Ethiopia and Guinea.","authors":"Anteneh Asefa, Lenka Beňová, Bruno Marchal, Charlotte Hanlon, Tamba Mina Millimouno, Mariamawit Asfaw, Özge Tunçalp, Tom Smekens, Alexandre Delamou, Samson Gebremedhin","doi":"10.1016/j.eclinm.2025.103702","DOIUrl":"10.1016/j.eclinm.2025.103702","url":null,"abstract":"<p><strong>Background: </strong>The mistreatment of women during facility-based childbirth is widespread in sub-Saharan Africa and has a negative impact on women's mental health. We aimed to examine the association between childbirth-related mistreatment and postpartum depression in Ethiopia and Guinea.</p><p><strong>Methods: </strong>Between May 2023 and February 2024, we conducted a prospective longitudinal survey of pregnant women recruited from 22 health facilities in Addis Ababa, Ethiopia, and 20 health facilities in Conakry, Guinea. Participants were surveyed during the third trimester in health facilities and were followed up in the community for a second survey, which was conducted between 6 and 16 weeks postpartum. Depression was assessed using the Edinburgh Postnatal Depression Scale (EPDS), and mistreatment was measured across seven categories. We used multilevel mixed effects Poisson regression to assess the association between the number of mistreatment categories experienced and women's postpartum depression scores.</p><p><strong>Findings: </strong>Of the 859 women enrolled during pregnancy, 711 women completed the postpartum survey. 87.4% of women in Addis Ababa and 71.2% in Conakry had experienced at least one category of mistreatment. Symptoms suggestive of postpartum depression (EPDS ≥11) were reported by 20.9% of women in Addis Ababa and 31.0% in Conakry. After adjusting for antepartum depression, intimate partner violence, and other sociodemographic, obstetric, and health service-related characteristics, experience of each additional mistreatment category was associated with a 5% increase in women's postpartum depression scores (adjusted incidence rate ratio [AIRR] = 1.05, 95% CI: 1.01-1.09). Among women without symptoms suggestive of antepartum depression (EPDS <11), the effect was even greater, with an 11% increase in postpartum depression scores (AIRR = 1.11; 95% CI: 1.06-1.17).</p><p><strong>Interpretation: </strong>The strong association between mistreatment and postpartum depression, particularly among women without antenatal depressive symptoms, highlights the potential causal role of mistreatment and underscores the urgent need for coordinated, evidence-informed, and context-appropriate strategies to promote respectful maternity care and safeguard women's mental health.</p><p><strong>Funding: </strong>Research Foundation Flanders (FWO file number 1261923N) and the Institute of Tropical Medicine (ITM), Antwerp, Belgium, with support from the Flemish Government Department of Economy, Science and Innovation (EWI) and the Belgian Federal Directorate-General for Development Cooperation and Humanitarian Aid (DGD).</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103702"},"PeriodicalIF":10.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12774692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145932233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-18eCollection Date: 2026-01-01DOI: 10.1016/j.eclinm.2025.103705
Bingyi Wang, Xufei Luo, Meihua Wu, Zijun Wang, Jie Zhang, Zijing Wang, Qianling Shi, Jiayi Liu, Wenhao Cao, Xiaoying Gu, Yaolong Chen, Bin Cao, Janne Estill
<p><strong>Background: </strong>Long COVID, a persistent condition following SARS-CoV-2 infection, exhibits diverse symptoms across multiple organ systems. This study aims to summarize the existing clustering and classification approaches to support the management of Long COVID.</p><p><strong>Methods: </strong>Following PRISMA guidelines, we systematically searched PubMed, Embase, Web of Science, and Google Scholar from their inception to January 21, 2025, and updated the search on October 1, 2025, to identify studies that presented a way to categorize Long COVID patients or symptoms. Data extraction and quality assessment were conducted for eligible studies. We presented symptom co-occurrence networks, and performed meta-analysis to estimate the percentage of different organ system-based symptom clusters. In addition, we conducted an exploratory analysis of the determinants of different symptom clusters. The protocol was registered in OSF (https://doi.org/10.17605/OSF.IO/J483F).</p><p><strong>Findings: </strong>Forty-seven cohort studies and 17 cross-sectional studies categorizing Long COVID subtypes or symptoms were included, encompassing 2.43 million participants across 20 countries. The methodological quality of the cohort studies was on average high (mean Newcastle-Ottawa scale score: 7.5/9), and of the 17 cross-sectional studies moderate (mean Joanna Briggs Institute tool score: 0.61/1.00). Patients or symptoms were categorized either according to the co-occurrence of symptoms (n = 30 studies, 46.9%); by the affected organ system (n = 16, 25.0%); by severity stratification (n = 9, 14.1%); by clinical indicators (n = 3, 4.7%); or by using other ways of classification (n = 6, 9.4%). Among the 30 studies defining patient clusters by the co-occurrence of symptoms, fatigue was the most frequently used descriptor for a cluster, either alone or together with other symptoms (n = 15 studies). Pairwise co-occurrence analysis revealed some commonly used symptom dyads, including olfactory-gustatory dysfunction (n = 10 times), anxiety-depression (n = 10) and joint pain/swelling-muscle pain (n = 9). Fatigue was a recurrent core symptom, frequently co-occurring with joint pain/swelling (n = 9 times) or muscle pain (n = 7), cognitive symptoms (n = 7), and dyspnea (n = 7). Meta-analysis of the organ system-based subtypes showed that respiratory symptom cluster had the highest pooled percentage (47% [95% CI: 29%-65%]), followed by neurological (31% [95% CI: 3%-60%]) and gastrointestinal clusters (28% [95% CI: 0%-57%]). These percentages represent the proportion of Long COVID patients with each symptom cluster within the 16 included organ system-based subtyping studies, not population-level prevalence of Long COVID. Exploratory analysis indicated that symptom subtypes were influenced by factors such as sex, age, virus variant, and comorbidities.</p><p><strong>Interpretation: </strong>This review identified four major approaches for categorizing Long COVID pat
{"title":"Identifying subtypes of Long COVID: a systematic review.","authors":"Bingyi Wang, Xufei Luo, Meihua Wu, Zijun Wang, Jie Zhang, Zijing Wang, Qianling Shi, Jiayi Liu, Wenhao Cao, Xiaoying Gu, Yaolong Chen, Bin Cao, Janne Estill","doi":"10.1016/j.eclinm.2025.103705","DOIUrl":"10.1016/j.eclinm.2025.103705","url":null,"abstract":"<p><strong>Background: </strong>Long COVID, a persistent condition following SARS-CoV-2 infection, exhibits diverse symptoms across multiple organ systems. This study aims to summarize the existing clustering and classification approaches to support the management of Long COVID.</p><p><strong>Methods: </strong>Following PRISMA guidelines, we systematically searched PubMed, Embase, Web of Science, and Google Scholar from their inception to January 21, 2025, and updated the search on October 1, 2025, to identify studies that presented a way to categorize Long COVID patients or symptoms. Data extraction and quality assessment were conducted for eligible studies. We presented symptom co-occurrence networks, and performed meta-analysis to estimate the percentage of different organ system-based symptom clusters. In addition, we conducted an exploratory analysis of the determinants of different symptom clusters. The protocol was registered in OSF (https://doi.org/10.17605/OSF.IO/J483F).</p><p><strong>Findings: </strong>Forty-seven cohort studies and 17 cross-sectional studies categorizing Long COVID subtypes or symptoms were included, encompassing 2.43 million participants across 20 countries. The methodological quality of the cohort studies was on average high (mean Newcastle-Ottawa scale score: 7.5/9), and of the 17 cross-sectional studies moderate (mean Joanna Briggs Institute tool score: 0.61/1.00). Patients or symptoms were categorized either according to the co-occurrence of symptoms (n = 30 studies, 46.9%); by the affected organ system (n = 16, 25.0%); by severity stratification (n = 9, 14.1%); by clinical indicators (n = 3, 4.7%); or by using other ways of classification (n = 6, 9.4%). Among the 30 studies defining patient clusters by the co-occurrence of symptoms, fatigue was the most frequently used descriptor for a cluster, either alone or together with other symptoms (n = 15 studies). Pairwise co-occurrence analysis revealed some commonly used symptom dyads, including olfactory-gustatory dysfunction (n = 10 times), anxiety-depression (n = 10) and joint pain/swelling-muscle pain (n = 9). Fatigue was a recurrent core symptom, frequently co-occurring with joint pain/swelling (n = 9 times) or muscle pain (n = 7), cognitive symptoms (n = 7), and dyspnea (n = 7). Meta-analysis of the organ system-based subtypes showed that respiratory symptom cluster had the highest pooled percentage (47% [95% CI: 29%-65%]), followed by neurological (31% [95% CI: 3%-60%]) and gastrointestinal clusters (28% [95% CI: 0%-57%]). These percentages represent the proportion of Long COVID patients with each symptom cluster within the 16 included organ system-based subtyping studies, not population-level prevalence of Long COVID. Exploratory analysis indicated that symptom subtypes were influenced by factors such as sex, age, virus variant, and comorbidities.</p><p><strong>Interpretation: </strong>This review identified four major approaches for categorizing Long COVID pat","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103705"},"PeriodicalIF":10.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12774694/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Low birth weight, defined as less than 2.5 kg (5.5 lbs) at birth, remains a critical global public health challenge. It significantly increases the risk of neonatal mortality and immediate complications such as sepsis and hypothermia, along with lifelong consequences including childhood disabilities and adult-onset chronic diseases. However, there was a limited study that described the spatial distribution and predictors of low birth weight in sub-Saharan Africa. The study aimed to assess geospatial variations and predictors of low birth weight in sub-Saharan Africa.
Methods: A community-based cross-sectional study design based on Demographic and Health Survey (2015-2024) data, comprising a weighted sample of 138,164 women aged 15-49 years with live births among 28 sub-Saharan African countries, was included in the study. Global Moran's I was calculated to determine overall clustering of low birth weight. Statistically significant hot spot and cold spot areas of low birth weight were determined by Getis-Ord G∗ statistics. Ordinary least squares, spatial lag, spatial error, geographically weighted regression, and multiscale geographically weighted regressions were utilized to determine predictors of low birth weight. The best-fitting models were determined by the highest R2 and the lowest corrected Akaike Information Criterion values. Finally, the statistically significant predictors from the final model were displayed on a map.
Findings: Low birth weight was clustered (Moran's I 0.23, z-score 50.2, p-value <0.01) in the study area. Significant hotspot areas were depicted in Mauritania, Mali, Senegal, Burkina Faso, Nigeria, Gabon, Angola, Madagascar, South Africa, Lesotho, Malawi, and Ethiopia. Conversely, low-risk cold spots were observed in Uganda, Kenya, Rwanda, Burundi, Tanzania, Zambia, Zimbabwe, Cameroon, and Sierra Leone. Short birth interval, no visit to a health facility in the last year, twin birth, no media exposure, and unemployed women were significant predictors of low birth weight.
Interpretation: There is spatial variation of low birth weight across different regions in sub-Saharan Africa. Significant hotspot and cold spot areas along with significant predictors were identified, which is a priority for policy makers. Targeted maternal health interventions, improved healthcare access, health education using mass media, and economic empowerment for women are recommended to reduce low birth weight.
Funding: None.
背景:低出生体重,定义为出生时低于2.5公斤(5.5磅),仍然是一个重大的全球公共卫生挑战。它大大增加了新生儿死亡和脓毒症和体温过低等即时并发症的风险,以及终身后果,包括儿童残疾和成人发病的慢性病。然而,有一项有限的研究描述了撒哈拉以南非洲低出生体重的空间分布和预测因素。该研究旨在评估撒哈拉以南非洲地区低出生体重的地理空间变化和预测因素。方法:基于人口与健康调查(2015-2024)数据的基于社区的横断面研究设计,包括28个撒哈拉以南非洲国家的138,164名年龄在15-49岁的活产妇女的加权样本。计算全球Moran's I以确定低出生体重的总体聚类。采用Getis-Ord G *统计方法确定低出生体重的热点区和冷点区具有统计学意义。利用普通最小二乘、空间滞后、空间误差、地理加权回归和多尺度地理加权回归来确定低出生体重的预测因子。最佳拟合模型由最高R2和最低修正的赤池信息准则值确定。最后,从最终模型中统计显著的预测因子显示在地图上。研究发现:低出生体重呈聚类(Moran's I = 0.23, z-score = 50.2, p值)。确定了重要的热点和冷点区域以及重要的预测因子,这是决策者的优先事项。建议采取有针对性的产妇保健干预措施、改善保健机会、利用大众媒体进行健康教育以及增强妇女经济权能,以减少低出生体重。资金:没有。
{"title":"Geospatial variations and predictors of low birth weight in Sub-Saharan Africa: a geospatial modeling using evidence from demographic health survey 2015-2024.","authors":"Bewketu Sendek Aragie, Getaneh Awoke Yismaw, Belayneh Jejaw Abate, Ashenafi Solomon Weldeyohanis, Solomon Gedlu Nigatu","doi":"10.1016/j.eclinm.2025.103693","DOIUrl":"10.1016/j.eclinm.2025.103693","url":null,"abstract":"<p><strong>Background: </strong>Low birth weight, defined as less than 2.5 kg (5.5 lbs) at birth, remains a critical global public health challenge. It significantly increases the risk of neonatal mortality and immediate complications such as sepsis and hypothermia, along with lifelong consequences including childhood disabilities and adult-onset chronic diseases. However, there was a limited study that described the spatial distribution and predictors of low birth weight in sub-Saharan Africa. The study aimed to assess geospatial variations and predictors of low birth weight in sub-Saharan Africa.</p><p><strong>Methods: </strong>A community-based cross-sectional study design based on Demographic and Health Survey (2015-2024) data, comprising a weighted sample of 138,164 women aged 15-49 years with live births among 28 sub-Saharan African countries, was included in the study. Global Moran's I was calculated to determine overall clustering of low birth weight. Statistically significant hot spot and cold spot areas of low birth weight were determined by Getis-Ord G∗ statistics. Ordinary least squares, spatial lag, spatial error, geographically weighted regression, and multiscale geographically weighted regressions were utilized to determine predictors of low birth weight. The best-fitting models were determined by the highest R<sup>2</sup> and the lowest corrected Akaike Information Criterion values. Finally, the statistically significant predictors from the final model were displayed on a map.</p><p><strong>Findings: </strong>Low birth weight was clustered (Moran's I 0.23, z-score 50.2, p-value <0.01) in the study area. Significant hotspot areas were depicted in Mauritania, Mali, Senegal, Burkina Faso, Nigeria, Gabon, Angola, Madagascar, South Africa, Lesotho, Malawi, and Ethiopia. Conversely, low-risk cold spots were observed in Uganda, Kenya, Rwanda, Burundi, Tanzania, Zambia, Zimbabwe, Cameroon, and Sierra Leone. Short birth interval, no visit to a health facility in the last year, twin birth, no media exposure, and unemployed women were significant predictors of low birth weight.</p><p><strong>Interpretation: </strong>There is spatial variation of low birth weight across different regions in sub-Saharan Africa. Significant hotspot and cold spot areas along with significant predictors were identified, which is a priority for policy makers. Targeted maternal health interventions, improved healthcare access, health education using mass media, and economic empowerment for women are recommended to reduce low birth weight.</p><p><strong>Funding: </strong>None.</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103693"},"PeriodicalIF":10.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12774685/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145932895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-18eCollection Date: 2026-01-01DOI: 10.1016/j.eclinm.2025.103675
Tracey Smythe, Sara Rotenberg, Maureen Moyo-Chilufya, Jane Wilbur, Hannah Kuper
Background: People with disabilities frequently experience poorer health than others in the population, yet the extent of this health gap is unknown. We undertook an umbrella review of meta-analyses to assess the amount, strength and quality of the evidence of the association between disability and a broad range of health outcomes.
Methods: We searched Cochrane Library, EMBASE, Medline, PsycINFO and Health Evidence to identify meta-analyses of quantitative studies, published January 1, 2000 to February 3, 2025, in any language. We included systematic reviews with meta-analyses that compared health outcomes between people with and without disabilities, across all study settings and geographical locations. Two reviewers assessed study eligibility and extracted data. We assessed risk of bias using the AMSTAR2 tool and evaluated the strength of evidence for each meta-analysis according to the Fusar-Poli and Radua criteria. We narratively described the association between disability and health outcomes, categorised according to ICD-11 categories. This study is registered with PROSPERO, CRD42025645729.
Findings: The search generated 11,221 unique records, of which 58 systematic reviews that included meta-analyses were included. Together, these reviews drew on 1409 primary studies from 77 countries and produced 132 separate meta-analyses that evaluated 16 health outcomes. Overall, most systematic reviews were of moderate to low quality. Intellectual and developmental disabilities accounted for the largest share of the meta-analyses (n = 60, 45%). One-third of associations (n = 45, 34%) showed convincing or highly suggestive evidence linking disability to adverse health outcomes. The majority of meta-analyses (n = 113, 86%) found statistically significant and positive associations. No studies that examined disability in relation to diseases of the blood, diseases of the immune system, diseases of the musculoskeletal system or conditions related to sexual health were identified.
Interpretation: People with disabilities are a diverse group, yet share the common experience of markedly worse health than their peers without disabilities. The evidence base is constrained by limited measurement of subjective health outcomes and definitions of disability that may not capture contextual factors. Consequently, the true association of disability and poor health outcomes may be underestimated. Health inequities experienced by people with disabilities necessitate health system reforms with efforts to embed inclusion and address social determinants of health.
Funding: The National Institute for Health and Care Research, the Programme for Evidence to Inform Disability Action grant from the Foreign, Commonwealth and Development Office, the Conrad N. Hilton Foundation.
{"title":"Health inequalities among people with disabilities: an umbrella review and evidence synthesis.","authors":"Tracey Smythe, Sara Rotenberg, Maureen Moyo-Chilufya, Jane Wilbur, Hannah Kuper","doi":"10.1016/j.eclinm.2025.103675","DOIUrl":"10.1016/j.eclinm.2025.103675","url":null,"abstract":"<p><strong>Background: </strong>People with disabilities frequently experience poorer health than others in the population, yet the extent of this health gap is unknown. We undertook an umbrella review of meta-analyses to assess the amount, strength and quality of the evidence of the association between disability and a broad range of health outcomes.</p><p><strong>Methods: </strong>We searched Cochrane Library, EMBASE, Medline, PsycINFO and Health Evidence to identify meta-analyses of quantitative studies, published January 1, 2000 to February 3, 2025, in any language. We included systematic reviews with meta-analyses that compared health outcomes between people with and without disabilities, across all study settings and geographical locations. Two reviewers assessed study eligibility and extracted data. We assessed risk of bias using the AMSTAR2 tool and evaluated the strength of evidence for each meta-analysis according to the Fusar-Poli and Radua criteria. We narratively described the association between disability and health outcomes, categorised according to ICD-11 categories. This study is registered with PROSPERO, CRD42025645729.</p><p><strong>Findings: </strong>The search generated 11,221 unique records, of which 58 systematic reviews that included meta-analyses were included. Together, these reviews drew on 1409 primary studies from 77 countries and produced 132 separate meta-analyses that evaluated 16 health outcomes. Overall, most systematic reviews were of moderate to low quality. Intellectual and developmental disabilities accounted for the largest share of the meta-analyses (n = 60, 45%). One-third of associations (n = 45, 34%) showed convincing or highly suggestive evidence linking disability to adverse health outcomes. The majority of meta-analyses (n = 113, 86%) found statistically significant and positive associations. No studies that examined disability in relation to diseases of the blood, diseases of the immune system, diseases of the musculoskeletal system or conditions related to sexual health were identified.</p><p><strong>Interpretation: </strong>People with disabilities are a diverse group, yet share the common experience of markedly worse health than their peers without disabilities. The evidence base is constrained by limited measurement of subjective health outcomes and definitions of disability that may not capture contextual factors. Consequently, the true association of disability and poor health outcomes may be underestimated. Health inequities experienced by people with disabilities necessitate health system reforms with efforts to embed inclusion and address social determinants of health.</p><p><strong>Funding: </strong>The National Institute for Health and Care Research, the Programme for Evidence to Inform Disability Action grant from the Foreign, Commonwealth and Development Office, the Conrad N. Hilton Foundation.</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103675"},"PeriodicalIF":10.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12775867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145932901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-18eCollection Date: 2026-01-01DOI: 10.1016/j.eclinm.2025.103695
Grant Matthew Smith, Cristiane D Bergerot, Andrew S Epstein, Judith E Nelson, Naveen Salins, Vasudeva Bhat K, Shirley Lewis, J Mac Skelton, Ravi B Parikh, Nirmala Bhoo-Pathy, Juan Borda, Beverley M Essue, Loreto Fernandez-Gonzalez, Madeline Li, Nancy Preston, Gilla K Shapiro, Dario Trapani, Karla Unger-Saldaña, Catherine Walshe, Camilla Zimmermann, Richard Sullivan, Gary Rodin, William E Rosa
Digital health tools improve the efficiency and quality of cancer care and are poised to have an even greater impact in the future. However, the extent to which these tools will enhance both disease-centered and human-centered care depends on which values, outcomes, and processes diverse stakeholders and sectors prioritize. Human-centered care recognizes the uniqueness and inherent value of individuals and values the inimitability of human relationships. In this Viewpoint, we call for prioritization of human-centered care in the design and implementation of digital health tools. After summarizing key ethical frameworks, we provide examples of digital innovations from Brazil, India, and the United States that demonstrate how choices in design, implementation, and evaluation can enhance human-centered care provision. In addition, we provide recommendations to support clinicians, researchers, and health systems in prioritizing human-centered care, including the involvement of patients, caregivers, and communities in all phases of design and implementation.
Funding: No funding was used in the creation of this manuscript. WER, ASE, and JEN are partially supported by the NIH/National Cancer Institute comprehensive cancer center award P30 CA008748. WER is supported by the Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program.
{"title":"Prioritizing human-centered cancer care in a digital era.","authors":"Grant Matthew Smith, Cristiane D Bergerot, Andrew S Epstein, Judith E Nelson, Naveen Salins, Vasudeva Bhat K, Shirley Lewis, J Mac Skelton, Ravi B Parikh, Nirmala Bhoo-Pathy, Juan Borda, Beverley M Essue, Loreto Fernandez-Gonzalez, Madeline Li, Nancy Preston, Gilla K Shapiro, Dario Trapani, Karla Unger-Saldaña, Catherine Walshe, Camilla Zimmermann, Richard Sullivan, Gary Rodin, William E Rosa","doi":"10.1016/j.eclinm.2025.103695","DOIUrl":"10.1016/j.eclinm.2025.103695","url":null,"abstract":"<p><p>Digital health tools improve the efficiency and quality of cancer care and are poised to have an even greater impact in the future. However, the extent to which these tools will enhance both disease-centered and human-centered care depends on which values, outcomes, and processes diverse stakeholders and sectors prioritize. Human-centered care recognizes the uniqueness and inherent value of individuals and values the inimitability of human relationships. In this Viewpoint, we call for prioritization of human-centered care in the design and implementation of digital health tools. After summarizing key ethical frameworks, we provide examples of digital innovations from Brazil, India, and the United States that demonstrate how choices in design, implementation, and evaluation can enhance human-centered care provision. In addition, we provide recommendations to support clinicians, researchers, and health systems in prioritizing human-centered care, including the involvement of patients, caregivers, and communities in all phases of design and implementation.</p><p><strong>Funding: </strong>No funding was used in the creation of this manuscript. WER, ASE, and JEN are partially supported by the NIH/National Cancer Institute comprehensive cancer center award P30 CA008748. WER is supported by the Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program.</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103695"},"PeriodicalIF":10.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12775855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-18eCollection Date: 2026-01-01DOI: 10.1016/j.eclinm.2025.103713
Katlyn G McKay, Catherine Beckhorn, Nelly-Ange T Kontchou, Zachary J Kastenberg, Jonathan Roach, Bhargava Mullapudi, Timothy B Lautz, Roshni Dasgupta, Lindsay J Talbot, Jennifer H Aldrink, Nelson Piché, Brian T Craig, Barrett Cromeens, Shannon L Castle, Joshua Short, Robin T Petroze, Peter Mattei, David H Rothstein, Elizabeth A Fialkowski, Barrie S Rich, Erin G Brown, Natashia M Seemann, Hau D Le, Tamer M Ahmed, Erika A Newman, Christa N Grant, Stephanie F Polites, Danielle B Cameron, Eugene S Kim, Mary T Austin, Brian A Coakley, Joseph T Murphy, Chloé Boehmer, Marcus M Malek, Elisabeth Tracy, Harold N Lovvorn
Background: Renal sarcomas arise rarely in children and adolescents and represent a histologically and biologically diverse disease category. Consequently, standardizing optimal therapies for pediatric renal sarcomas remains challenging. Leveraging a large North American research collaborative, the purposes of this study were to evaluate the current state of patient, disease, and survival characteristics among pediatric renal sarcomas and to expose knowledge gaps that will inform future discovery.
Methods: Patients 21 years or younger and treated for a primary renal sarcoma between January 1st, 2000 and November 30th, 2022 were identified through the Pediatric Surgical Oncology Research Collaborative. Patient (e.g., demographics) and disease (e.g., histology, stage, molecular alterations) characteristics were abstracted from contributing institutions. Descriptive statistics, Pearson-Chi square (categorical variables), Kruskal-Wallis (continuous variables), Cox regression (Hazard ratios), and Kaplan-Meier 4-year event-free and overall survival (OS) analyses were completed.
Findings: Among 158 patients, clear cell sarcoma of the kidney (CCSK; n = 94), Ewing sarcoma (EWS; n = 33), and undifferentiated sarcoma (n = 8) predominated. Sarcoma type correlated significantly with age at diagnosis (p < 0.0001), with infantile fibrosarcoma (IFS) and CCSK occurring in the youngest patients, whereas EWS and synovial sarcoma presented in the oldest. Predisposition syndromes were identified in 11/155 (7.1%) patients, most commonly DICER1 and Li-Fraumeni. Multimodal therapies varied significantly across sarcoma types (p = 0.0008), although nephrectomy was uniform. Tumor thrombectomy was performed in 9 patients (6 with EWS). When tested, somatic molecular alterations were observed principally in CCSK (17/38; 45%) and EWS (26/26; 100%; p = 0.001). At 4 years, OS differed significantly by sarcoma type, ranging from highest to lowest as follows: CCSK 0.927 (95% CI 0.845-0.967), EWS 0.901 (95% CI 0.723-0.967), undifferentiated sarcoma 0.833 (95% CI 0.273-0.975), IFS 0.667 (95% CI 0.054-0.945), and rhabdomyosarcoma 0.500 (95% CI 0.111-0.804; p = 0.036). Hematogenous metastases occurred most in the lungs (n = 19 total; 10 with EWS), followed by bone (n = 12), which occurred only with CCSK (n = 9) and EWS (n = 3). Two patients developed brain metastases (one each with CCSK and rhabdomyosarcoma). At 4 years, OS was 0.957 (95% CI 0.888-0.984) for patients presenting without metastases and 0.717 (95% CI 0.545-0.833) for those with metastases (p = 0.00015).
Interpretation: Renal sarcomas presenting in children and adolescents comprise a heterogeneous disease category with unique patient, clinical, and molecular characteristics that complicate standardizing therapeutic strategies beyond CCSK and EWS.
Funding: None.
背景:肾肉瘤很少发生在儿童和青少年中,是一种组织学和生物学上多样化的疾病类别。因此,标准化儿童肾肉瘤的最佳治疗方法仍然具有挑战性。利用北美大型研究合作,本研究的目的是评估儿童肾肉瘤患者的现状、疾病和生存特征,并揭示知识空白,为未来的发现提供信息。方法:在2000年1月1日至2022年11月30日期间接受原发性肾肉瘤治疗的21岁或以下患者通过儿科外科肿瘤研究协作确定。患者(如人口统计学)和疾病(如组织学、分期、分子改变)特征从贡献机构中抽象出来。完成描述性统计、Pearson-Chi平方(分类变量)、Kruskal-Wallis(连续变量)、Cox回归(风险比)和Kaplan-Meier 4年无事件和总生存(OS)分析。结果:158例患者中,肾透明细胞肉瘤(CCSK, n = 94)、Ewing肉瘤(EWS, n = 33)和未分化肉瘤(n = 8)占主导地位。肉瘤类型与诊断年龄显著相关(p < 0.0001),婴儿纤维肉瘤(IFS)和CCSK发生在最年轻的患者中,而EWS和滑膜肉瘤出现在最年长的患者中。在11/155(7.1%)患者中发现易感综合征,最常见的是DICER1和Li-Fraumeni。不同肉瘤类型的多模式治疗差异显著(p = 0.0008),尽管肾切除术是一致的。9例患者行肿瘤取栓术(其中6例为EWS)。检测时,体细胞分子改变主要见于CCSK(17/38; 45%)和EWS (26/26; 100%; p = 0.001)。4年时,不同肉瘤类型的OS差异显著,从最高到最低的范围如下:CCSK 0.927 (95% CI 0.845-0.967), EWS 0.901 (95% CI 0.723-0.967),未分化肉瘤0.833 (95% CI 0.274 -0.975), IFS 0.667 (95% CI 0.054-0.945),横纹肌肉瘤0.500 (95% CI 0.111-0.804; p = 0.036)。血液转移最多发生在肺部(共19例,EWS 10例),其次是骨(12例),仅发生在CCSK(9例)和EWS(3例)。2例患者发生脑转移(CCSK和横纹肌肉瘤各1例)。4年时,无转移患者的OS为0.957 (95% CI 0.888-0.984),有转移患者的OS为0.717 (95% CI 0.545-0.833) (p = 0.00015)。结论:儿童和青少年肾肉瘤是一种异质性疾病,具有独特的患者、临床和分子特征,使CCSK和EWS之外的标准化治疗策略复杂化。资金:没有。
{"title":"Renal sarcomas in children and adolescents: a retrospective, multicenter cohort study.","authors":"Katlyn G McKay, Catherine Beckhorn, Nelly-Ange T Kontchou, Zachary J Kastenberg, Jonathan Roach, Bhargava Mullapudi, Timothy B Lautz, Roshni Dasgupta, Lindsay J Talbot, Jennifer H Aldrink, Nelson Piché, Brian T Craig, Barrett Cromeens, Shannon L Castle, Joshua Short, Robin T Petroze, Peter Mattei, David H Rothstein, Elizabeth A Fialkowski, Barrie S Rich, Erin G Brown, Natashia M Seemann, Hau D Le, Tamer M Ahmed, Erika A Newman, Christa N Grant, Stephanie F Polites, Danielle B Cameron, Eugene S Kim, Mary T Austin, Brian A Coakley, Joseph T Murphy, Chloé Boehmer, Marcus M Malek, Elisabeth Tracy, Harold N Lovvorn","doi":"10.1016/j.eclinm.2025.103713","DOIUrl":"10.1016/j.eclinm.2025.103713","url":null,"abstract":"<p><strong>Background: </strong>Renal sarcomas arise rarely in children and adolescents and represent a histologically and biologically diverse disease category. Consequently, standardizing optimal therapies for pediatric renal sarcomas remains challenging. Leveraging a large North American research collaborative, the purposes of this study were to evaluate the current state of patient, disease, and survival characteristics among pediatric renal sarcomas and to expose knowledge gaps that will inform future discovery.</p><p><strong>Methods: </strong>Patients 21 years or younger and treated for a primary renal sarcoma between January 1st, 2000 and November 30th, 2022 were identified through the Pediatric Surgical Oncology Research Collaborative. Patient (e.g., demographics) and disease (e.g., histology, stage, molecular alterations) characteristics were abstracted from contributing institutions. Descriptive statistics, Pearson-Chi square (categorical variables), Kruskal-Wallis (continuous variables), Cox regression (Hazard ratios), and Kaplan-Meier 4-year event-free and overall survival (OS) analyses were completed.</p><p><strong>Findings: </strong>Among 158 patients, clear cell sarcoma of the kidney (CCSK; n = 94), Ewing sarcoma (EWS; n = 33), and undifferentiated sarcoma (n = 8) predominated. Sarcoma type correlated significantly with age at diagnosis (p < 0.0001), with infantile fibrosarcoma (IFS) and CCSK occurring in the youngest patients, whereas EWS and synovial sarcoma presented in the oldest. Predisposition syndromes were identified in 11/155 (7.1%) patients, most commonly DICER1 and Li-Fraumeni. Multimodal therapies varied significantly across sarcoma types (p = 0.0008), although nephrectomy was uniform. Tumor thrombectomy was performed in 9 patients (6 with EWS). When tested, somatic molecular alterations were observed principally in CCSK (17/38; 45%) and EWS (26/26; 100%; p = 0.001). At 4 years, OS differed significantly by sarcoma type, ranging from highest to lowest as follows: CCSK 0.927 (95% CI 0.845-0.967), EWS 0.901 (95% CI 0.723-0.967), undifferentiated sarcoma 0.833 (95% CI 0.273-0.975), IFS 0.667 (95% CI 0.054-0.945), and rhabdomyosarcoma 0.500 (95% CI 0.111-0.804; p = 0.036). Hematogenous metastases occurred most in the lungs (n = 19 total; 10 with EWS), followed by bone (n = 12), which occurred only with CCSK (n = 9) and EWS (n = 3). Two patients developed brain metastases (one each with CCSK and rhabdomyosarcoma). At 4 years, OS was 0.957 (95% CI 0.888-0.984) for patients presenting without metastases and 0.717 (95% CI 0.545-0.833) for those with metastases (p = 0.00015).</p><p><strong>Interpretation: </strong>Renal sarcomas presenting in children and adolescents comprise a heterogeneous disease category with unique patient, clinical, and molecular characteristics that complicate standardizing therapeutic strategies beyond CCSK and EWS.</p><p><strong>Funding: </strong>None.</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103713"},"PeriodicalIF":10.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12775861/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145932220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17eCollection Date: 2026-01-01DOI: 10.1016/j.eclinm.2025.103700
Tengteng Wang, Elisa V Bandera, Marley Perlstein, Nur Zeinomar, Karen Pawlish, Coral Omene, Kitaw Demissie, Christine B Ambrosone, Chi-Chen Hong, Bo Qin
<p><strong>Background: </strong>Epidemiological evidence on the influence of ultra-processed foods (UPFs) on breast cancer prognosis is scarce. No study has examined the UPF-mortality association among Black breast cancer survivors.</p><p><strong>Methods: </strong>We examined the UPF-mortality relationships among Black women diagnosed with primary breast cancer in New Jersey between 2005 and 2019 (n = 1733), who were participants of the Women's Circle of Health Study and Women's Circle of Health Follow-Up Study. Foods and drinks consumed one year before breast cancer diagnosis were assessed during home interviews by validated food-frequency questionnaires. UPFs were classified according to their degree of processing using the standard NOVA classification system. Death outcomes were ascertained through linkage with New Jersey State Cancer Registry files. Multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for UPF-mortality associations were estimated using Cox and competing risks models, as appropriate.</p><p><strong>Findings: </strong>After a median of 9.3 years of follow-up since diagnosis, 394 total deaths (206 breast cancer-related) were identified. In the multivariable-adjusted model, compared to those in the lowest tertile (median = 2.6 servings/day), women in the highest tertile (median = 8.1 servings/day) of UPF intake had statistically significantly higher breast cancer-specific mortality (HR = 1.40, 95% CI = 1.00-1.96, P<sub>trend</sub> = 0.02) and all-cause mortality (HR = 1.36, 95% CI = 1.06-1.74, P<sub>trend</sub> <0.01). Dose-response analyses revealed a J-shaped association of UPF intake with mortality outcome, with lower risk at under 4 servings/day and higher risk at greater consumption (breast cancer mortality P<sub>for nonlinearity</sub> = 0.01). These associations were attenuated after additional adjustment for total energy intake.</p><p><strong>Interpretation: </strong>This large investigation of UPFs and breast cancer prognosis among Black breast cancer survivors suggests that higher consumption of UPFs, which is associated with greater total energy intake, may adversely influence breast cancer prognosis among Black women, a vulnerable population facing the highest risk of breast cancer mortality in the US.</p><p><strong>Funding: </strong>This work was supported by grants from R01CA185623 (Drs. Bandera, Demissie, and Hong), P30CA072720-5929 (Dr. Bandera), R01CA100598 (Dr. Ambrosone), P01CA151135 (Drs Ambrosone, Palmer, and Olshan), R00CA267557 (Dr. Wang) from the National Cancer Institute, and funding from the American Cancer Society RSG-23-1143513-01-CTPS (Dr. Qin) and the Breast Cancer Research Foundation (Dr. Ambrosone). The New Jersey State Cancer Registry, Cancer Epidemiology Services, New Jersey Department of Health, is funded by the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute under contract 75N91021D00009, the National Program of Cancer Registries
{"title":"Ultra-processed foods consumption and subsequent mortality in a cohort of Black breast cancer survivors.","authors":"Tengteng Wang, Elisa V Bandera, Marley Perlstein, Nur Zeinomar, Karen Pawlish, Coral Omene, Kitaw Demissie, Christine B Ambrosone, Chi-Chen Hong, Bo Qin","doi":"10.1016/j.eclinm.2025.103700","DOIUrl":"10.1016/j.eclinm.2025.103700","url":null,"abstract":"<p><strong>Background: </strong>Epidemiological evidence on the influence of ultra-processed foods (UPFs) on breast cancer prognosis is scarce. No study has examined the UPF-mortality association among Black breast cancer survivors.</p><p><strong>Methods: </strong>We examined the UPF-mortality relationships among Black women diagnosed with primary breast cancer in New Jersey between 2005 and 2019 (n = 1733), who were participants of the Women's Circle of Health Study and Women's Circle of Health Follow-Up Study. Foods and drinks consumed one year before breast cancer diagnosis were assessed during home interviews by validated food-frequency questionnaires. UPFs were classified according to their degree of processing using the standard NOVA classification system. Death outcomes were ascertained through linkage with New Jersey State Cancer Registry files. Multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for UPF-mortality associations were estimated using Cox and competing risks models, as appropriate.</p><p><strong>Findings: </strong>After a median of 9.3 years of follow-up since diagnosis, 394 total deaths (206 breast cancer-related) were identified. In the multivariable-adjusted model, compared to those in the lowest tertile (median = 2.6 servings/day), women in the highest tertile (median = 8.1 servings/day) of UPF intake had statistically significantly higher breast cancer-specific mortality (HR = 1.40, 95% CI = 1.00-1.96, P<sub>trend</sub> = 0.02) and all-cause mortality (HR = 1.36, 95% CI = 1.06-1.74, P<sub>trend</sub> <0.01). Dose-response analyses revealed a J-shaped association of UPF intake with mortality outcome, with lower risk at under 4 servings/day and higher risk at greater consumption (breast cancer mortality P<sub>for nonlinearity</sub> = 0.01). These associations were attenuated after additional adjustment for total energy intake.</p><p><strong>Interpretation: </strong>This large investigation of UPFs and breast cancer prognosis among Black breast cancer survivors suggests that higher consumption of UPFs, which is associated with greater total energy intake, may adversely influence breast cancer prognosis among Black women, a vulnerable population facing the highest risk of breast cancer mortality in the US.</p><p><strong>Funding: </strong>This work was supported by grants from R01CA185623 (Drs. Bandera, Demissie, and Hong), P30CA072720-5929 (Dr. Bandera), R01CA100598 (Dr. Ambrosone), P01CA151135 (Drs Ambrosone, Palmer, and Olshan), R00CA267557 (Dr. Wang) from the National Cancer Institute, and funding from the American Cancer Society RSG-23-1143513-01-CTPS (Dr. Qin) and the Breast Cancer Research Foundation (Dr. Ambrosone). The New Jersey State Cancer Registry, Cancer Epidemiology Services, New Jersey Department of Health, is funded by the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute under contract 75N91021D00009, the National Program of Cancer Registries","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103700"},"PeriodicalIF":10.0,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17eCollection Date: 2026-01-01DOI: 10.1016/j.eclinm.2025.103710
Sandra Martínez-Rodríguez, Inmaculada Ortiz-Esquinas, Juan Miguel Martínez-Galiano, Ana Ballesta-Castillejos, Victoria Mazoteras-Pardo, Antonio Hernández-Martínez
Background: Higher pre-pregnancy body mass index (BMI) has been associated with obstetric complications and proposed as a psychosocial risk factor for postpartum depression (PPD). However, its relationship with postpartum post-traumatic stress disorder (PP-PTSD) and perceived obstetric violence has not been sufficiently investigated. We aimed to examine the association between pre-pregnancy BMI and perinatal mental health outcomes.
Methods: We conducted a retrospective cohort study in Spain in 2023 using a self-administered online questionnaire completed by 2363 women between one and six months postpartum. Outcomes included high perception of obstetric violence (CARE-MQ > p90), risk of PP-PTSD (PPQ ≥ p90), and PPD (EPDS ≥12). Pre-pregnancy BMI was categorized according to WHO criteria. Multivariable logistic regression models adjusted for sociodemographic, clinical, and obstetric confounders were used.
Findings: Women with higher pre-pregnancy BMI had a higher frequency of medical interventions (induction of labor, oxytocin, regional analgesia) and more birth complications (aOR 1.69, 95% CI 1.21-2.34). Higher pre-pregnancy BMI was independently associated with increased risk of PPD (aOR 1.44, 95% CI 1.05-1.97), but not with PP-PTSD or perceived obstetric violence. Protective factors included older maternal age, higher income, attendance at childbirth preparation classes, adherence to the birth plan, skin-to-skin contact, and early initiation of breastfeeding. Complicated births and failure to adhere to the birth plan were associated with increased risk of experiencing at least one postpartum mental health problem.
Interpretation: Higher pre-pregnancy BMI may be linked to increased vulnerability to postpartum depression. This relationship appears influenced by obstetric characteristics and care practices, underscoring the need for further research and for preventive strategies to improve respectful, stigma-free perinatal care for women with higher pre-pregnancy BMI.
Funding: This study was funded by Instituto de Salud Carlos III (project PI22/00541) and co-funded by the European Union.
背景:较高的孕前体重指数(BMI)与产科并发症有关,并被认为是产后抑郁症(PPD)的社会心理危险因素。然而,其与产后创伤后应激障碍(PP-PTSD)和感知产科暴力的关系尚未得到充分调查。我们的目的是检查孕前BMI和围产期心理健康结果之间的关系。方法:我们于2023年在西班牙进行了一项回顾性队列研究,使用2363名产后1至6个月的妇女自行填写的在线问卷。结果包括对产科暴力的高感知(CARE-MQ > p90), PP-PTSD (PPQ≥p90)和PPD (EPDS≥12)的风险。根据世卫组织的标准对孕前BMI进行分类。采用多变量logistic回归模型调整社会人口、临床和产科混杂因素。研究结果:孕前BMI较高的妇女接受医疗干预(引产、催产素、局部镇痛)的频率更高,分娩并发症也更多(aOR 1.69, 95% CI 1.21-2.34)。较高的孕前BMI与PPD风险增加独立相关(aOR 1.44, 95% CI 1.05-1.97),但与PP-PTSD或感知的产科暴力无关。保护性因素包括母亲年龄较大、收入较高、参加分娩准备课程、遵守分娩计划、皮肤接触和早期开始母乳喂养。复杂的分娩和未能坚持分娩计划与经历至少一种产后心理健康问题的风险增加有关。解释:怀孕前较高的身体质量指数可能与产后抑郁症的易感性增加有关。这种关系似乎受到产科特征和护理实践的影响,强调需要进一步研究和制定预防战略,以改善对孕前体重指数较高的妇女的尊重和无耻辱感的围产期护理。经费:本研究由Salud Carlos III研究所资助(项目PI22/00541),欧盟共同资助。
{"title":"Pre-gestational BMI, obstetric violence, and perinatal mental health: a retrospective cohort study.","authors":"Sandra Martínez-Rodríguez, Inmaculada Ortiz-Esquinas, Juan Miguel Martínez-Galiano, Ana Ballesta-Castillejos, Victoria Mazoteras-Pardo, Antonio Hernández-Martínez","doi":"10.1016/j.eclinm.2025.103710","DOIUrl":"10.1016/j.eclinm.2025.103710","url":null,"abstract":"<p><strong>Background: </strong>Higher pre-pregnancy body mass index (BMI) has been associated with obstetric complications and proposed as a psychosocial risk factor for postpartum depression (PPD). However, its relationship with postpartum post-traumatic stress disorder (PP-PTSD) and perceived obstetric violence has not been sufficiently investigated. We aimed to examine the association between pre-pregnancy BMI and perinatal mental health outcomes.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study in Spain in 2023 using a self-administered online questionnaire completed by 2363 women between one and six months postpartum. Outcomes included high perception of obstetric violence (CARE-MQ > p90), risk of PP-PTSD (PPQ ≥ p90), and PPD (EPDS ≥12). Pre-pregnancy BMI was categorized according to WHO criteria. Multivariable logistic regression models adjusted for sociodemographic, clinical, and obstetric confounders were used.</p><p><strong>Findings: </strong>Women with higher pre-pregnancy BMI had a higher frequency of medical interventions (induction of labor, oxytocin, regional analgesia) and more birth complications (aOR 1.69, 95% CI 1.21-2.34). Higher pre-pregnancy BMI was independently associated with increased risk of PPD (aOR 1.44, 95% CI 1.05-1.97), but not with PP-PTSD or perceived obstetric violence. Protective factors included older maternal age, higher income, attendance at childbirth preparation classes, adherence to the birth plan, skin-to-skin contact, and early initiation of breastfeeding. Complicated births and failure to adhere to the birth plan were associated with increased risk of experiencing at least one postpartum mental health problem.</p><p><strong>Interpretation: </strong>Higher pre-pregnancy BMI may be linked to increased vulnerability to postpartum depression. This relationship appears influenced by obstetric characteristics and care practices, underscoring the need for further research and for preventive strategies to improve respectful, stigma-free perinatal care for women with higher pre-pregnancy BMI.</p><p><strong>Funding: </strong>This study was funded by Instituto de Salud Carlos III (project PI22/00541) and co-funded by the European Union.</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103710"},"PeriodicalIF":10.0,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17eCollection Date: 2026-01-01DOI: 10.1016/j.eclinm.2025.103697
Donna Wakefield, Tara Dehpour, Clare Bambra, Joanna Davies, Fliss E M Murtagh, Jonathan Koffman
Background: People from socioeconomically deprived backgrounds are at greater risk of developing lung disease and having a higher symptom burden. It remains unclear whether they have equitable access to and experience of palliative care. Therefore, we aimed to synthesise evidence on socioeconomic inequalities in access, receipt of, preference for, and experience of palliative care among people with advanced lung disease.
Methods: Mixed-methods systematic review, searching four databases (MEDLINE, Embase, PsychINFO, CINAHL) from inception to March 28, 2025. We included studies that reported on socioeconomic position and palliative care in advanced lung disease (lung cancer, mesothelioma, chronic obstructive pulmonary disease, interstitial lung disease). Study quality was assessed using the Mixed Methods Appraisal Tool. Both meta-analysis (using a random effects model with I2 to assess heterogeneity, sensitivity analysis and GRADE of evidence) and narrative synthesis were performed. PROSPERO CRD42024546502.
Findings: Of 10,572 records, 54 studies met inclusion criteria (4.2 million participants). Meta-analysis of six studies showed people with lung cancer in the lowest SEP group were 18% less likely to receive palliative care than those in the highest (OR 0.82, 95% CI 0.75-0.90, I2 = 93.9%). GRADE of evidence was assessed as moderate. Qualitative findings identified financial hardship and insurance barriers limited access to pain relief and oxygen. Few studies considered multiple demographic characteristics, but those that did reported worse access among ethnic minorities and rural populations.
Interpretation: This review provides novel evidence of how the inverse care law operates in advanced lung disease. People from lower socioeconomic groups are significantly less likely to access palliative care, despite greater need. There is an urgent need for equity-focused research and policy interventions, co-produced with underserved communities that account for intersecting social disadvantages.
Funding: National Institute for Health and Care Research.
背景:来自社会经济贫困背景的人患肺病的风险更高,症状负担也更高。目前尚不清楚他们是否有公平的机会获得和体验姑息治疗。因此,我们的目的是综合晚期肺病患者在姑息治疗的获取、接受、偏好和经验方面的社会经济不平等的证据。方法:采用混合方法进行系统评价,检索MEDLINE、Embase、PsychINFO、CINAHL 4个数据库,检索时间为建库至2025年3月28日。我们纳入了报道晚期肺病(肺癌、间皮瘤、慢性阻塞性肺病、间质性肺病)的社会经济地位和姑息治疗的研究。采用混合方法评价工具评价研究质量。meta分析(使用I2随机效应模型来评估异质性、敏感性分析和证据等级)和叙事综合。普洛斯彼罗CRD42024546502。结果:在10572项记录中,54项研究符合纳入标准(420万参与者)。6项研究的荟萃分析显示,最低SEP组肺癌患者接受姑息治疗的可能性比最高SEP组低18% (OR 0.82, 95% CI 0.75-0.90, I2 = 93.9%)。证据等级评定为中等。定性研究发现,经济困难和保险障碍限制了获得止痛和氧气的机会。很少有研究考虑到多种人口统计学特征,但那些考虑到这一点的研究报告称,少数民族和农村人口的入学率较低。解释:这篇综述为晚期肺部疾病的逆护理规律提供了新的证据。社会经济地位较低群体的人获得姑息治疗的可能性明显较低,尽管需求更大。迫切需要以公平为重点的研究和政策干预,与服务不足的社区共同开展,这些社区是造成交叉社会不利因素的原因。资助:国家卫生和保健研究所。
{"title":"The inverse palliative care law in advanced lung disease: a mixed-methods systematic review and meta-analysis.","authors":"Donna Wakefield, Tara Dehpour, Clare Bambra, Joanna Davies, Fliss E M Murtagh, Jonathan Koffman","doi":"10.1016/j.eclinm.2025.103697","DOIUrl":"10.1016/j.eclinm.2025.103697","url":null,"abstract":"<p><strong>Background: </strong>People from socioeconomically deprived backgrounds are at greater risk of developing lung disease and having a higher symptom burden. It remains unclear whether they have equitable access to and experience of palliative care. Therefore, we aimed to synthesise evidence on socioeconomic inequalities in access, receipt of, preference for, and experience of palliative care among people with advanced lung disease.</p><p><strong>Methods: </strong>Mixed-methods systematic review, searching four databases (MEDLINE, Embase, PsychINFO, CINAHL) from inception to March 28, 2025. We included studies that reported on socioeconomic position and palliative care in advanced lung disease (lung cancer, mesothelioma, chronic obstructive pulmonary disease, interstitial lung disease). Study quality was assessed using the Mixed Methods Appraisal Tool. Both meta-analysis (using a random effects model with I<sup>2</sup> to assess heterogeneity, sensitivity analysis and GRADE of evidence) and narrative synthesis were performed. PROSPERO CRD42024546502.</p><p><strong>Findings: </strong>Of 10,572 records, 54 studies met inclusion criteria (4.2 million participants). Meta-analysis of six studies showed people with lung cancer in the lowest SEP group were 18% less likely to receive palliative care than those in the highest (OR 0.82, 95% CI 0.75-0.90, I<sup>2</sup> = 93.9%). GRADE of evidence was assessed as moderate. Qualitative findings identified financial hardship and insurance barriers limited access to pain relief and oxygen. Few studies considered multiple demographic characteristics, but those that did reported worse access among ethnic minorities and rural populations.</p><p><strong>Interpretation: </strong>This review provides novel evidence of how the inverse care law operates in advanced lung disease. People from lower socioeconomic groups are significantly less likely to access palliative care, despite greater need. There is an urgent need for equity-focused research and policy interventions, co-produced with underserved communities that account for intersecting social disadvantages.</p><p><strong>Funding: </strong>National Institute for Health and Care Research.</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103697"},"PeriodicalIF":10.0,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770954/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17eCollection Date: 2026-01-01DOI: 10.1016/j.eclinm.2025.103676
Jos Verbeek
{"title":"Errors in Liu et al. 'Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis'.","authors":"Jos Verbeek","doi":"10.1016/j.eclinm.2025.103676","DOIUrl":"10.1016/j.eclinm.2025.103676","url":null,"abstract":"","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":"91 ","pages":"103676"},"PeriodicalIF":10.0,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12774696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145932944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}